10 mg · 20 mg · 30 mg · 50 mg
Retatrutide
Investigational peptide targeting GIP, GLP-1 and glucagon receptors. Studied in clinical trials on body weight and glycemic control.
For research use only
NAD+
Cellular coenzyme studied in energy metabolism, redox reactions and metabolite changes.
- Pay by card (Stripe) or Zelle
- Ships within the U.S. with tracking
- Questions? Call or email us
Benefits under study
Biochemical research and pilot metabolism studies.
- Cellular energy metabolism
- Oxidation-reduction reactions
- Changes in NAD+ metabolites
Research overview
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It takes part in the oxidation-reduction reactions at the core of energy metabolism and is studied in mitochondrial function, redox biology, DNA-repair pathways and cellular aging research.
Research explores how NAD+ and its metabolites change under different conditions, including a pilot study of the human plasma and urine NAD+ metabolome during intravenous infusion.
Supplied as a 1,000 mg vial for laboratory research.
Scientific references
A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD
Front Aging Neurosci, 2019 · PMID 31572171
View on PubMed
You may also need
10 mg · 20 mg
Tesamorelin
GHRH analog studied in GH/IGF-1 signaling and visceral fat, including trials in people with HIV and altered fat distribution.
100 mg
KLOW
Blend of GHK-Cu, BPC-157, TB-500 and KPV. Studies on the individual components do not evaluate the blend.